| Stay updated on the top DIGITAL HEALTH NEWS |
|---|
|
|
InnoStars is recruiting participants for its fellowship program (StarShip) from InnoStars countries and other RIS eligible countries outside EIT Health. StarShip is an EIT Health educational initiative in collaboration with leading European health industrial partners - lead by the University of Coimbra and IESE Business School and the Royal Institute of Technology (KTH).
CUBE, a global ecosystem dedicated to connecting startups and corporations, opened its new collaboration space in Berlin. The space is the official point of connection between CUBE's curated startups and its partners. CUBE aims to facilitate even greater connections between industry leaders and innovative B2B startups by placing teams side by side.
Novartis has announced the launch of an innovative technology-based healthcare program called SMS for Life 2.0 in Kaduna State, Nigeria. The program aims to increase the availability of essential medicines and improve care for patients across the region by using simple, available, and affordable technology.
This publication provides an overview of the scope and organisation of health and elderly care in Denmark. The healthcare system operates across three political and administrative levels: the state, the regions and the municipalities (national, regional and local levels).
The state holds the overall regulatory and supervisory functions in health and elderly care. The five regions are primarily responsible for the hospitals, the general practitioners (GPs) and for psychiatric care. The 98 municipalities are responsible for a number of primary healthcare services as well as for elderly care.
Giving people with disabilities the power to control objects with their minds, automating breast health monitoring and a wireless injectable device for connected drug delivery services are among the innovative technologies being developed by the eight semifinalists selected for the Accenture HealthTech Innovation Challenge.
10 - 12 May 2017, Malta.
IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) have announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer.